Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: MYLAN LABORATORIES INC

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of MYLAN LABORATORIES INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of MYLAN LABORATORIES INC since year 2005. Table 2 shows the detailed insider transactions of MYLAN LABORATORIES INC since 2005. The reporting company's ticker symbol is MYL. The reporting company's CIK number is 69499.
1 year chart,   5 day chart,   1 day chart.

The total value of stock buying since 2005 is $28,439,322. The total value of stock sales is $21,524,436. The total value of stock exercises is $10,619,385.


Figure 1. Monthly insider transaction values at MYLAN LABORATORIES INC (MYL) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • $24,999k

    $2,499k

    $249k

    $24k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at MYLAN LABORATORIES INC (MYL) in the past 24 months. See table 2 for insider transaction details.

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • $22.24

    $16.68

    $11.12

    $5.56



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for MYLAN LABORATORIES INC (MYL).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-03 86,700 914,815 0 0 53,924 0
2008-01 0 0 0 0 5,300 41,811
2007-11 0 0 0 0 6,000 47,333
2007-08 38,400 578,414 0 0 0 0
2007-07 41,200 573,887 0 0 10,000 78,889
2007-06 74,000 1,372,243 0 0 0 0
2007-02 1,199,039 24,999,963 75,000 1,667,999 75,000 1,020,000
2007-01 0 0 75,000 1,575,000 75,000 1,020,000
2006-12 0 0 120,000 2,474,796 120,000 1,316,664
2006-11 0 0 20,000 411,232 0 0
2006-09 0 0 108,100 2,207,639 108,100 1,332,044
2006-04 0 0 25,000 588,750 25,000 340,000
2006-03 0 0 40,000 916,000 40,000 544,000
2006-02 0 0 340,000 7,331,420 340,000 4,334,644
2006-01 0 0 40,000 825,200 40,000 544,000
2005-07 0 0 200,000 3,526,400 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for MYLAN LABORATORIES INC (MYL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-03-18 Malik Rajiv (Head of Global Tech. Ops.) Option Exercise 8,525 .00 0
2008-03-18 Bresch Heather M (Chief Operating Officer) Option Exercise 8,525 .00 0
2008-03-18 Coury Robert J (Vice Chairman, CEO) Option Exercise 25,575 .00 0
2008-03-18 Borkowski Edward (Chief Financial Officer) Option Exercise 8,525 .00 0
2008-03-18 Rizzo Daniel C Jr (Corporate Controller) Option Exercise 2,774 .00 0
2008-03-17 Maroon Joseph C Md (Director) Purchase 2,000 11.00 22,000
2008-03-14 Malik Rajiv (Head of Global Tech. Ops.) Purchase 5,000 10.96 54,797
2008-03-13 Dimick Neil F (Director) Purchase 4,700 10.58 49,719
2008-03-13 Cameron Wendy (Director) Purchase 5,000 10.64 53,200
2008-03-10 Piatt Rodney L (Director) Purchase 5,000 10.38 51,899
2008-03-10 Bresch Heather M (Chief Operating Officer) Purchase 5,000 10.39 51,950
2008-03-10 Borkowski Edward (Chief Financial Officer) Purchase 5,000 10.38 51,900
2008-03-07 Williams Stuart A (Special Counsel, Office of CEO) Purchase 10,000 10.55 105,500
2008-03-07 Coury Robert J (Vice Chairman, CEO) Purchase 20,000 10.14 202,800
2008-03-06 Coury Robert J (Vice Chairman, CEO) Purchase 10,000 10.74 107,400
2008-03-05 Coury Robert J (Vice Chairman, CEO) Purchase 15,000 10.91 163,650
2008-01-22 Korman Harry (President, North America) Option Exercise 5,300 7.89 41,811
2007-11-13 Korman Harry (President, North America) Option Exercise 6,000 7.89 47,333
2007-08-10 Maroon Joseph C Md (Director) Purchase 1,000 14.72 14,720
2007-08-10 Coury Robert J (Vice Chairman, CEO) Purchase 10,000 14.02 140,200
2007-08-08 Piatt Rodney L (Director) Purchase 4,400 15.04 66,154
2007-08-08 Williams Stuart A (Chief Legal Officer) Purchase 5,000 14.87 74,335
2007-08-07 Maroon Joseph C Md (Director) Purchase 1,500 15.23 22,849
2007-08-03 Williams Stuart A (Chief Legal Officer) Purchase 15,000 15.71 235,650
2007-08-02 Maroon Joseph C Md (Director) Purchase 1,500 16.34 24,506
2007-07-27 Piatt Rodney L (Director) Purchase 5,000 16.68 83,400
2007-07-27 Coury Robert J (Vice Chairman, CEO) Purchase 20,000 16.74 334,858
2007-07-27 Cameron Wendy (Director) Purchase 6,200 16.10 99,820
2007-07-27 Todd C B (Director) Purchase 10,000 5.58 55,809
2007-07-26 Korman Harry (Pres., Mylan Pharmaceuticals) Option Exercise 10,000 7.89 78,889
2007-06-15 Coury Robert J (Vice Chairman, CEO) Purchase 35,000 18.57 650,049
2007-06-15 Borkowski Edward (Chief Financial Officer) Purchase 5,000 18.56 92,800
2007-06-14 Coury Robert J (Vice Chairman, CEO) Purchase 15,000 18.44 276,645
2007-06-12 Piatt Rodney L (Director) Purchase 4,000 18.65 74,600
2007-02-15 Nimmagadda Prasad (Head of Global Strategies) Purchase 1,199,039 20.85 24,999,963
2007-02-01 Williams Stuart A (Chief Legal Officer) Sale 75,000 22.24 1,667,999
2007-02-01 Williams Stuart A (Chief Legal Officer) Option Exercise 75,000 13.60 1,020,000
2007-01-22 Williams Stuart A (Chief Legal Officer) Sale 75,000 21.00 1,575,000
2007-01-22 Williams Stuart A (Chief Legal Officer) Option Exercise 75,000 13.60 1,020,000
2006-12-14 Korman Harry (Pres., Mylan Pharmaceuticals) Sale 120,000 20.62 2,474,796
2006-12-14 Korman Harry (Pres., Mylan Pharmaceuticals) Option Exercise 120,000 10.97 1,316,664
2006-11-21 Odonnell John (Chief Scientific Officer) Sale 20,000 20.56 411,232
2006-09-15 Sphar Gary (CFO, Mylan Pharmaceuticals Inc) Sale 8,100 21.20 171,699
2006-09-15 Sphar Gary (CFO, Mylan Pharmaceuticals Inc) Option Exercise 8,100 11.58 93,824
2006-09-12 Odonnell John (Chief Scientific Officer) Sale 100,000 20.36 2,035,940
2006-09-12 Odonnell John (Chief Scientific Officer) Option Exercise 100,000 12.38 1,238,220
2006-04-03 Williams Stuart A (Chief Legal Officer) Sale 25,000 23.55 588,750
2006-04-03 Williams Stuart A (Chief Legal Officer) Option Exercise 25,000 13.60 340,000
2006-03-01 Williams Stuart A (Chief Legal Officer) Sale 40,000 22.90 916,000
2006-03-01 Williams Stuart A (Chief Legal Officer) Option Exercise 40,000 13.60 544,000
2006-02-14 Govil Sharad Kumar (Vice President) Sale 20,000 22.19 443,740
2006-02-14 Govil Sharad Kumar (Vice President) Option Exercise 20,000 10.97 219,444
2006-02-10 Odonnell John (Chief Scientific Officer) Sale 200,000 21.45 4,290,000
2006-02-10 Odonnell John (Chief Scientific Officer) Option Exercise 200,000 12.38 2,476,400
2006-02-09 Borkowski Edward (Chief Financial Officer) Sale 80,000 21.95 1,755,680
2006-02-09 Borkowski Edward (Chief Financial Officer) Option Exercise 80,000 13.68 1,094,800
2006-02-03 Williams Stuart A (Chief Legal Officer) Sale 40,000 21.05 842,000
2006-02-03 Williams Stuart A (Chief Legal Officer) Option Exercise 40,000 13.60 544,000
2006-01-05 Williams Stuart A (Chief Legal Officer) Sale 40,000 20.63 825,200
2006-01-05 Williams Stuart A (Chief Legal Officer) Option Exercise 40,000 13.60 544,000
2005-07-29 Sunseri Patricia (Sr. Vice President) Sale 200,000 17.63 3,526,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of MYLAN LABORATORIES INC (symbol MYL, CIK number 69499) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.